Financial Services

A new Phase 2 trial for an oral pill offers hope for patients with M. abscessus lung disease, a severe infection with no approved treatments.

Successful trials of high-yield castor seeds in Brazil show economic viability, positioning the non-edible crop as a major new feedstock for biofuels.

J.Jill reports falling sales and a Q4 loss, yet boosts its dividend, betting on a strategic overhaul to navigate tariff pressures and a tough retail market.

With exports topping 5 million tons, Indonesia's palm waste is a key energy source for Japan, which is now eyeing new EFB pellets for its future.

A new partnership between TORRAS and the Portuguese Football Federation shifts focus from the final score to the daily grind with a revolutionary new product line.

As a wall of corporate debt looms over Europe, the investment firm hires a top specialist to lead its expansion and capitalize on market dislocations.

From Chinese labs to Pakistani fields, a pioneering dry-land farming project is tackling climate change and cultivating a new generation of scientific diplomats.

Landmark study results show a new drug-coated balloon significantly improves outcomes for Peripheral Artery Disease, heralding a major shift in treatment.

A global analytics firm and Special Olympics are tackling a huge sports gap for women with disabilities in Asia, proving inclusion is everyone's game.

A new, highly selective oral drug for the most common form of dwarfism has been cleared for U.S. trials, offering hope for a more convenient treatment.

A shocking new installation reveals a dangerous blind spot: your car isn't protecting you from the sun's harmful rays. Here's what you need to know.

MBK Rental Living's new Las Brisas community offers resort-style amenities, but its launch highlights the complex housing pressures on California's Central Coast.

The diagnostics firm posts strong thyroid growth after a strategic shift, but a one-time tax adjustment inflates its impressive 2025 bottom line.

NASDAQ-listed Bio Green Med Solution abandons its biopharma roots for fire safety, slashing losses but facing new questions about its long-term survival.

A new bipartisan bill introduced at the TMCF Fly-In aims to overhaul federal research funding access for HBCUs, addressing a stark inequity in STEM.

Supplement brand Bucked Up launches a nearly $5M campaign with an in-house ad and a massive giveaway. Can this bold strategy shake up the energy drink market?

Sound Transit's new Crosslake Connection is a world-first engineering marvel, reshaping travel, tourism, and daily life across the Puget Sound region.

The Evaluation Company's new approval to certify foreign nurses promises to disrupt a slow market and offer a new pathway to ease US healthcare shortages.

Subway Canada's new multi-year deal with the Toronto Blue Jays is more than just signage; it's a strategic play in the competitive QSR sports market.

Luxury brand Perfect Moment lands a $12M financing package, including an equity deal at a 75% premium, signaling a major vote of confidence for its China expansion.